United States Cancer Vaccine Market Product, Application, End-User Industry, and Geography - Global Forecast to 2025
26th September 2018 - United
States Cancer Vaccines Market
is expected to grow at a significant CAGR in the upcoming years as the scope,
product types, and its applications are increasing across the globe. Vaccines
come across as remedies that stimulate the immune system of the body to defend
against foreign substances. The stimulated immune system kills foreign bodies.
Vaccines work on the principle of recalling foreign element and avoid
contamination likely to be produced by this foreign particle when it attacks
again.
Additionally,
cancer vaccines enhance body’s natural immune system to fight against cancer
cells. Cancer treatment vaccines abolish cancer cells left in the body after
the other treatments, stop cancer from recurring, and stop additional spreading
of cancer. Cancer vaccines could be directed intravenously in adults as well as
in children.
View Full Report
with TOC @ https://www.millioninsights.com/industry-reports/united-states-cancer-vaccines-market
The
factors that drive the growth of Cancer Vaccines are growing technological
development, increasing cancer cases, rising innovations pertaining to cancer,
increasing government initiatives, growing aged population in the region. On
the other hand, the factors that hamper the growth of Cancer Vaccines are
Stringent rules and regulation procedures of governments, Cold chain, or lack
of temperature-controlled supply chain management, less accessibility to
vaccines in the remote regions.
United
States Cancer Vaccines Market is categorized based on product type,
applications, and geography. United States Cancer Vaccines Market is
categorized based on product types such as Prophylactic Vaccines, Therapeutic
Vaccines. United States Cancer Vaccines Market is categorized based on
application to Adults, Children. United States Cancer Vaccines Market is
categorized based on geography into The West, The Southwest, The Middle
Atlantic, New England, The South and The Midwest.
Some
of the key players that fuel the growth of the United States Cancer Vaccines
Market include Merck, Sanofi, Galena Biopharma, Amgen, Isa Pharmaceuticals,
Bristol-Myers Squibb, Bavarian Nordic, GlaxoSmithKline, Inovio Pharmaceuticals,
Antigen Express, Biothera, Prima BioMed, Juvaris Biotherapeutics, Provectus
Biopharmaceuticals, Dendreon, Oxford BioMedica, Celldex Therapeutics, Aduro
BioTech, Northwest Biotherapeutics, Vaxon Biotech. The key players are focusing
on inorganic growth to sustain themselves amidst fierce competition. As such,
mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
Geographically, this report splits the
United States market into seven regions:
•
The West
•
Southwest
•
The Middle Atlantic
•
New England
•
The South
•
The Midwest
with
sales (volume), revenue (value), market share and growth rate of Cancer Vaccine
in these regions, from 2013 to 2025 (forecast).
United States Cancer Vaccine market
competition by top manufacturers/players, with Cancer Vaccine sales volume,
price, revenue (Million USD) and market share for each manufacturer/player; the
top players including
•
Dendreon Corporation
•
NeoStem Oncology
•
ImmunoGen
•
Inovio Pharmaceuticals
•
Novartis
Request Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/united-states-cancer-vaccines-market/request-sample
Comments
Post a Comment